Mychael V. Lourenco, Ph.D.
Institute of Medical Biochemistry Leopoldo de Meis
Universidade Federal do Rio de Janeiro
2023 – Distinguished Researcher – Brazil Conference
2022 – 11 Early Career Scientist to Watch – Nature Medicine
2022 – Blas Frangione Early Career Achievement Award – Alzheimer’s Association
2021 – IBRO Early Career Award – International Brain Research Organization
2021 – Affiliate Member of the Brazilian Academy of Sciences
2020 – Young IBRO Regions Connecting Award – International Brain Research Organization
2017 – 1st SBBq/Biozeus Innovation Prize, Brazilian Society for Biochemistry and Molecular Biology, Brazil
2017 – Vital Brazil Best PhD Thesis Award – Biological, Health and Agricultural Sciences, Brazilian Federal Foundation for Higher Education (CAPES) – Ministry of Education
2017 – Finalist – 21st Young Talent Award in Life Sciences, Brazilian Society for Biochemistry and Molecular Biology, Brazil
2016 – Finalist – 20th Young Talent Award in Life Sciences, Brazilian Society for Biochemistry and Molecular Biology, Brazil
Mychael received his B.Sc. degree in Genetics (2010), his MSc (2012) and PhD (2016) from the Federal University of Rio de Janeiro. He further conducted postdoctoral training at the same university. He was a visiting collaborator at Columbia University (New York) and is an Assistant Professor of Neuroscience at the Institute of Medical Biochemistry Leopoldo de Meis (Federal University of Rio de Janeiro). He is a Productivity Fellow Level 2 of the Brazilian Council for Scientific Research and Development (CNPq PQ2), an Young Scientist Fellow of the Rio de Janeiro State Science Agency (Jovem Cientista FAPERJ) and an Affiliate Member of the Brazilian Academy of Sciences.
Mychael is a handling editor for the Journal of Neurochemistry and Alzheimer’s & Dementia: Translational Research and Clinical Investigations and a committee member on the Global Membership Committee (Society for Neuroscience). He has served on several society committees, including the SfN’s Trainee Advisory Committee (2016-2019) and Online Program Steering Committee (2017-2021) and the Young Scientist Steering Committee of the International Society for Neurochemistry (2017-2021).
Mychael has experience in cellular and molecular neuroscience and is specifically interested in molecular mechanisms of Alzheimer’s disease. His training at the Fernanda De Felice and Sergio Ferreira’s labs led him to describe mechanisms that cause neuronal stress and memory loss in AD models. Research in the Lourenco Lab aims to establish the molecular mechanisms of cognitive dysfunction associated with neurological disease and propose potential targets for effective intervention.